Thus, we investigated the effect of GV1001 on the TNF-α-induced EndMT using HUVEC cells and found that GV1001 notably inhibited the EndMT process induced by TNF-α, a major proinflammatory cytokine responsible for the development and progression of atherosclerosis. The gene discussed is TNF; the disease is atherosclerosis.